Skip to Content

RDY 353 (Rivastigmine Tartrate 3 mg)

Pill with imprint RDY 353 is Brown, Capsule-shape and has been identified as Rivastigmine Tartrate 3 mg. It is supplied by Dr. Reddy's Laboratories Ltd..

Rivastigmine is used in the treatment of parkinson's disease; alzheimer's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 3 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 353

Rivastigmine tartrate 3 mg RDY 353

Rivastigmine Tartrate

Imprint
RDY 353
Strength
3 mg
Color
Brown
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy's Laboratories Ltd.
National Drug Code (NDC)
55111-0353

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.